NEDA-3 status including cortical lesions in the comparative evaluation of natalizumab versus fingolimod efficacy in multiple sclerosis

por Puthenparampil, Marco, Cazzola, Chiara, Zywicki, Sofia, Federle, Lisa, Stropparo, Erica, Anglani, Mariagiulia, Rinaldi, Francesca, Perini, Paola, Gallo, Paolo
Publicado 2018

Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis

por Puthenparampil, Marco, Stropparo, Erica, Zywicki, Sofia, Bovis, Francesca, Cazzola, Chiara, Federle, Lisa, Grassivaro, Francesca, Rinaldi, Francesca, Perini, Paola, Sormani, Maria Pia, Gallo, Paolo
Publicado 2020